These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 20852292)
1. A study of blood soluble P-selectin, fibrinogen, and von Willebrand factor levels in idiopathic and lone atrial fibrillation. Fu R; Wu S; Wu P; Qiu J Europace; 2011 Jan; 13(1):31-6. PubMed ID: 20852292 [TBL] [Abstract][Full Text] [Related]
2. Thrombogenesis in lone atrial fibrillation: a role for soluble P-selectin? Montoro-García S; Marín F; Lip GY Europace; 2011 Jan; 13(1):3-4. PubMed ID: 20974759 [No Abstract] [Full Text] [Related]
3. Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation. Conway DS; Buggins P; Hughes E; Lip GY J Am Coll Cardiol; 2004 Jun; 43(11):2075-82. PubMed ID: 15172416 [TBL] [Abstract][Full Text] [Related]
4. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function. Li-Saw-Hee FL; Blann AD; Gurney D; Lip GY Eur Heart J; 2001 Sep; 22(18):1741-7. PubMed ID: 11511124 [TBL] [Abstract][Full Text] [Related]
5. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels. Freestone B; Chong AY; Nuttall S; Lip GY Thromb Res; 2008; 122(1):85-90. PubMed ID: 17996280 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial. Varughese GI; Patel JV; Tomson J; Blann AD; Hughes EA; Lip GY J Intern Med; 2007 Apr; 261(4):384-91. PubMed ID: 17391113 [TBL] [Abstract][Full Text] [Related]
8. Circulating progenitor cells in patients with atrial fibrillation and their relation with serum markers of inflammation and angiogenesis. Watson T; Shantsila E; Blann A; Lip GY Thromb Haemost; 2010 Aug; 104(2):327-34. PubMed ID: 20508899 [TBL] [Abstract][Full Text] [Related]
9. Effect of acute exercise on the raised plasma fibrinogen, soluble P-selectin and von Willebrand factor levels in chronic atrial fibrillation. Li-Saw-Hee FL; Blann AD; Edmunds E; Gibbs CR; Lip GY Clin Cardiol; 2001 May; 24(5):409-14. PubMed ID: 11346250 [TBL] [Abstract][Full Text] [Related]
10. Correlation of plasma von Willebrand factor levels, an index of endothelial damage/dysfunction, with two point-based stroke risk stratification scores in atrial fibrillation. Roldán V; Marín F; García-Herola A; Lip GY Thromb Res; 2005; 116(4):321-5. PubMed ID: 16038717 [TBL] [Abstract][Full Text] [Related]
11. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report. Lip GY; Blann AD; Zarifis J; Beevers M; Lip PL; Beevers DG J Hypertens; 1995 Dec; 13(12 Pt 2):1674-8. PubMed ID: 8903631 [TBL] [Abstract][Full Text] [Related]
12. Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a 'real-world' community cohort of patients with atrial fibrillation. Krishnamoorthy S; Khoo CW; Lim HS; Lane DA; Pignatelli P; Basili S; Violi F; Lip GY Eur J Clin Invest; 2013 Oct; 43(10):1032-8. PubMed ID: 23961715 [TBL] [Abstract][Full Text] [Related]
13. Effects of radiofrequency catheter ablation of atrial fibrillation on soluble P-selectin, von Willebrand factor and IL-6 in the peripheral and cardiac circulation. Kornej J; Dinov B; Blann AD; Rolf S; Arya A; Schmidl J; Husser D; Hindricks G; Bollmann A; Lip GY PLoS One; 2014; 9(11):e111760. PubMed ID: 25390649 [TBL] [Abstract][Full Text] [Related]
14. Effects of toll-like receptor-4 gene polymorphisms on soluble P-selectin and von Willebrand factor levels in hypercholesterolemic patients. Di Nisio M; Di Febbo C; Moretta V; Guglielmi MD; Stuppia L; Cuccurullo F; Porreca E Thromb Haemost; 2007 Sep; 98(3):642-6. PubMed ID: 17849054 [TBL] [Abstract][Full Text] [Related]
15. Atrial fibrillation and the prothrombotic state in the elderly: the Rotterdam Study. Conway DS; Heeringa J; Van Der Kuip DA; Chin BS; Hofman A; Witteman JC; Lip GY Stroke; 2003 Feb; 34(2):413-7. PubMed ID: 12574552 [TBL] [Abstract][Full Text] [Related]
16. [Changes of endothelial function indices and their relation to platelet activation in idiopathic atrial fibrillation]. Fu RB; Wu PS; Wu SL; Qiu J Nan Fang Yi Ke Da Xue Xue Bao; 2010 Apr; 30(4):771-3. PubMed ID: 20423847 [TBL] [Abstract][Full Text] [Related]
17. Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease. Freestone B; Lip GY; Chong AY; Nadar S; Lee KW; Blann AD Thromb Haemost; 2005 Oct; 94(4):702-6. PubMed ID: 16270620 [TBL] [Abstract][Full Text] [Related]
18. Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm. Choudhury A; Chung I; Blann AD; Lip GY J Am Coll Cardiol; 2007 May; 49(19):1957-64. PubMed ID: 17498581 [TBL] [Abstract][Full Text] [Related]
19. A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation. Li-Saw-Hee FL; Blann AD; Lip GY J Am Coll Cardiol; 2000 Jun; 35(7):1926-31. PubMed ID: 10841245 [TBL] [Abstract][Full Text] [Related]
20. Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation. Freestone B; Chong AY; Nuttall S; Blann AD; Lip GY Chest; 2007 Oct; 132(4):1253-8. PubMed ID: 17890461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]